Recursion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discov…

Biotechnology
US, Salt Lake City [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of RXRX's Analysis
CIK: 1601830 CUSIP: 75629V104 ISIN: US75629V1044 LEI: - UEI: -
Secondary Listings
RXRX has no secondary listings inside our databases.